Westlake Set To Join S&P MidCap 400, Replacing MillerKnoll; MillerKnoll To Replace Covetrus In S&P SmallCap 600
October 13, 5:23 PM
Westlake Corp. (NYSE:WLK) will replace MillerKnoll Inc. (NASD:MLKN) in the S&P MidCap 400, and MillerKnoll will replace Covetrus Inc. (NASD:CVET) in the S&P SmallCap 600 effective prior to the opening of trading on Tuesday, October 18.
U.S. Supreme Court Lifts Block On Generic Version Of Novartis Blockbuster Multiple Sclerosis Drug
October 13, 5:16 PM
-Reuters
‘Take-Two Is Shutting New York Studio Behind Popular Mobile Game Dots’ -Bloomberg
October 13, 5:14 PM
https://www.bloomberg.com/news/articles/2022-10-13/take-two-shuts-playdots-game-studio-in-new-york-cutting-65-jobs?sref=DWzi38c2
Oceaneering Wins $300M Of Subsea Robotics Contracts During Q3’22
October 13, 5:02 PM
Oceaneering International, Inc. (NYSE:OII) announces that its Subsea Robotics segment won multiple contracts during the third quarter of 2022, with anticipated aggregate revenue of $300 million. These
Washington Federal Q4 EPS $1.07 Up From $0.72 YoY
October 13, 5:01 PM
Washington Federal (NASDAQ:WAFD) reported quarterly earnings of $1.07 per share. This is a 48.61 percent increase over earnings of $0.72 per share from the same period last year.
FCPT Announces Acquisition Of Advance Auto Parts Property For $715K
October 13, 4:56 PM
Four Corners Property Trust (NYSE:FCPT), a real estate investment trust primarily engaged in the ownership and acquisition of high-quality, net-leased restaurant and retail properties ("FCPT" or the
Ring Energy Provides Operational Update, Lowered Fourth Quarter Capital Expenditure Guidance, Issued FY23 Capital Expenditure Guidance
October 13, 4:50 PM
Ring Energy, Inc. (NYSE:REI) ("Ring" or the "Company") today provided an operational update for the third quarter and full year 2022, revised guidance for the fourth
Reata Pharmaceuticals Announces FDA Does Not Plan To Hold Advisory Committee Meeting To Discuss The NDA For Omaveloxolone For Friedreich’s Ataxia
October 13, 4:38 PM
Reata Pharmaceuticals, Inc. (NASDAQ:RETA) ("Reata," the "Company," "our," "us," or "we"), a clinical-stage biopharmaceutical company, announced that the U.S. Food